Iovance Biotherapeutics, Inc.
IOVA • NASDAQ • Stock Fundamentals
Iovance Biotherapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Frederick G. Vogt, with a market cap of $1.8B.
Market Cap$1.8B
Employees557.0
CEOFrederick G. Vogt
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Iovance Biotherapeutics, Inc. FAQ
Common questions about Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. (IOVA) has a market capitalization of $1.8B and trades on NASDAQ.
Iovance Biotherapeutics, Inc. has approximately 557 employees.